<h1>Deep-tech firm raises $17.8M via third-party allotment to fund R&D, manufacturing scale-up, Japan and US market entry</h1> A private deep-tech company reported a Series B financing of USD 17.8 million (approx. Rs 157.83 crore) through a third-party allotment. The funds are designated for R&D expansion, scaling manufacturing, and market entry into jurisdictions including Japan and the United States, with existing demonstration projects in several European countries. Legal considerations arising from the transaction include compliance with securities laws governing third-party allotments, corporate governance and disclosure obligations, cross-border investment and export controls, environmental and product-regulatory approvals for bio-based polymers, and intellectual property protection and licensing in target markets.